Abstract

INADEQUATE IRON THERAPY CANNOT PREVENT ANEMIA FOLLOWING CHEMOTHERAPY IN BREAST CANCER PATIENTS

Dr. Saha Tanima*, Dr. Banerjee Sanatan, Dr. Bhattacharyya Swati,Dr. Biswas Supreeti

ABSTRACT

Context: Anemia is a frequent finding in cancer patients, occurring in >40% of cases. Incidence of anemia may rise to 90% after chemotherapy. Anemia exerts a negative influence on the quality of life of cancer patients. Aims: To observe prevalence and incidence of chemotherapy induced anemia in breast cancer patients, with prior and concomitant iron supplementation in our setting. Settings and Design: A retrospective cum prospective study was conducted for 6 months in Radiotherapy Department of our institute. Methods and Materials: Patients receiving chemotherapy regimen comprised of 5- Fluorouracil, Doxorubicin and Cyclophosphamide, with prior iron supplementation were selected. Data regarding patients’ demographic profile, regimen given and hemoglobin level were collected. Patients were considered to be anemic if hemoglobin value was

Keywords: Anemia, Breast cancer, Chemotherapy, 5-Fluorouracil, Adriamycin and Cyclophosphamide.